Similar Papers

Paper Title
Journal
Date
Author
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
Darius Sairafi ... Jonas Mattsson
Biology of Blood and Marrow Transplantation | VOL. 16
Darius Sairafi, et. al.Darius Sairafi ... Jonas Mattsson
10 Jun 2010
Targeting Molecular Remission with Donor Lymphocyte Infusions Shows Excellent Outcomes for Persistent or Relapsed Myelofibrosis after Stem Cell Transplantation
Nico Gagelmann ... Nicolaus Kroeger
Blood | VOL. 140
Nico Gagelmann, et. al.Nico Gagelmann ... Nicolaus Kroeger
15 Nov 2022
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center
Paolo Anderlini ... Richard E Champlin
Leukemia & Lymphoma | VOL. 53
Paolo Anderlini, et. al.Paolo Anderlini ... Richard E Champlin
05 Jan 2012
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose
Merav Bar ... Mary E.D Flowers
Blood | VOL. 120
Merav Bar, et. al.Merav Bar ... Mary E.D Flowers
16 Nov 2012
View more papers

More From: Blood

Paper Title
Journal
Date
Author
How I approach pharmacological thromboprophylaxis in children.
Anthony A Sochet ... Neil A Goldenberg
Blood | VOL. -
Anthony A Sochet, et. al.Anthony A Sochet ... Neil A Goldenberg
03 Feb 2025
Woyach JA, Burbano GP, Ruppert AS, etal. Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood. 2024;143(16):1616-1627.
-
Blood | VOL. 145
--
30 Jan 2025
A novel therapy with a rational design for AML.
Maria L Amaya
Blood | VOL. 145
Maria L AmayaMaria L Amaya
30 Jan 2025
For how long has this problem been there?
Niccolò Bolli ... Matteo Claudio Da Vià
Blood | VOL. 145
Niccolò Bolli, et. al.Niccolò Bolli ... Matteo Claudio Da Vià
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.